Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
3-benzodiazole sodium
Clin Infect Dis
Chemical Name: 2-(4-Morpholinyl)-4H-pyrimido[2
It inhibits proliferation of P388 leukemia cells with an IC50 value of 20 μg/ml
Axitinib Catalog No.:M11394-2 3-benzodiazole sodiumAxitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet derived growth factor receptor (PDGF), thereby exerting an anti angiogenic effect. A xitinib has received FDA (27 January 2012), EMA (13 September 2012), MHRA (3 September 2012) and TGA (26 July 2012) approval for use as a treatment for renal cell carcinoma. Product